Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Lymphangioleiomyoma of the Uterus and Pelvic Lymph Nodes: A Report of 3 Cases, Including the Potentially Earliest Manifestation of Extrapulmonary Lymphangioleiomyomatosis.

Ando H, Ogawa M, Watanabe Y, Tsurunaga K, Nakamura C, Tamura H, Ikeda K, Takahashi R, Nakajima R, Yoshida S, Tsujie T, Doi R, Wakimoto A, Adachi S.

Int J Gynecol Pathol. 2019 Feb 14. doi: 10.1097/PGP.0000000000000589. [Epub ahead of print]

PMID:
30789500
2.

Homologous Expression and Characterization of Gassericin T and Gassericin S, a Novel Class IIb Bacteriocin Produced by Lactobacillus gasseri LA327.

Kasuga G, Tanaka M, Harada Y, Nagashima H, Yamato T, Wakimoto A, Arakawa K, Kawai Y, Kok J, Masuda T.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02815-18. doi: 10.1128/AEM.02815-18. Print 2019 Mar 15.

PMID:
30610075
3.

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28.

PMID:
29080971
4.

Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review.

Ando H, Watanabe Y, Ogawa M, Tamura H, Deguchi T, Ikeda K, Fujitani M, Shioji M, Tsujie T, Doi R, Wakimoto A, Adachi S.

Diagn Pathol. 2017 Aug 25;12(1):63. doi: 10.1186/s13000-017-0655-y. Review.

5.

Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.

Adachi K, Takahashi K, Nakamura K, Otake A, Sasamoto N, Miyoshi Y, Shioji M, Yamamoto Y, Fujitani M, Wakimoto A, Tokuhira A, Kobayashi E, Yoshimura A, Sawada K, Kimura T.

Gynecol Endocrinol. 2016 Aug;32(8):646-649. Epub 2016 Feb 18.

PMID:
26890948
6.

Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.

Egawa-Takata T, Ueda Y, Kuragaki C, Miyake T, Miyatake T, Fujita M, Yoshino K, Nakashima R, Okazawa M, Tsutsui T, Morishige K, Kimura T, Yamasaki M, Nishizaki T, Nagamatsu M, Ito K, Asada M, Ogita K, Wakimoto A, Yamamoto T, Nishio Y, Enomoto T.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1603-10. doi: 10.1007/s00280-011-1638-4. Epub 2011 May 17.

PMID:
21584840
7.

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.

Ueno Y, Enomoto T, Otsuki Y, Sugita N, Nakashima R, Yoshino K, Kuragaki C, Ueda Y, Aki T, Ikegami H, Yamazaki M, Ito K, Nagamatsu M, Nishizaki T, Asada M, Kameda T, Wakimoto A, Mizutani T, Yamada T, Murata Y.

Cancer Lett. 2006 Sep 28;241(2):289-300. Epub 2006 Feb 3.

PMID:
16459017
8.

Regulation of classical HLA class I genes in human choriocarcinoma cells by nuclear proteins binding to MHC class I regulatory elements.

Wakimoto A, Ohashi K, Koyama M, Kato M, Tsutsui T, Saji F, Tanizawa O.

Am J Reprod Immunol. 1995 Nov;34(5):323-31.

PMID:
8595132
9.

Selection of acrosome-reacted sperm with MH61-immunobeads.

Ohashi K, Saji F, Wakimoto A, Tsutsui T, Nakazawa T, Okabe M, Mimura T, Tanizawa O.

J Androl. 1994 Jan-Feb;15(1):78-82.

10.

Preparation of oligozoospermic and/or asthenozoospermic semen for intrauterine insemination using the SpermPrep semen filtration column.

Ohashi K, Saji F, Wakimoto A, Kato M, Tsutsui T, Tanizawa O.

Fertil Steril. 1992 Apr;57(4):866-70.

PMID:
1313377
11.

Tumor necrosis factor-alpha inhibits human chorionic gonadotropin secretion.

Ohashi K, Saji F, Kato M, Wakimoto A, Tanizawa O.

J Clin Endocrinol Metab. 1992 Jan;74(1):130-4.

PMID:
1727811
12.

Expression of HLA class I and beta 2-microglobulin on human choriocarcinoma cell lines: induction of HLA class I by interferon-gamma.

Kato M, Ohashi K, Saji F, Wakimoto A, Tanizawa O.

Placenta. 1991 May-Jun;12(3):217-26.

PMID:
1754572
13.

HLA expression on human ejaculated sperm.

Ohashi K, Saji F, Kato M, Wakimoto A, Tanizawa O.

Am J Reprod Immunol. 1990 May;23(1):29-32.

PMID:
2118766
14.

HLA expression on sperm cell surface.

Ohashi K, Kato M, Wakimoto A, Saji F, Tanizawa O.

Nihon Sanka Fujinka Gakkai Zasshi. 1989 Apr;41(4):497-8. No abstract available.

PMID:
2746074
15.

Comparison of Biobrane and Scarlet Red dressings for treatment of donor site wounds.

Zapata-Sirvent R, Hansbrough JF, Carroll W, Johnson R, Wakimoto A.

Arch Surg. 1985 Jun;120(6):743-5.

PMID:
3890805
16.

Clinical experience with Biobrane biosynthetic dressing in the treatment of partial thickness burns.

Hansbrough JF, Zapata-Sirvent R, Carroll WJ, Dominic WJ, Wang XW, Wakimoto A.

Burns Incl Therm Inj. 1984 Aug;10(6):415-9.

PMID:
6478287
17.

Studies of the low-molecular-weight keratinase inhibitor of human epidermis.

Takiuchi I, Koga M, Takagi H, Wakimoto A.

J Dermatol. 1984 Apr;11(2):155-9. No abstract available.

PMID:
6384310
18.

[Purification of a low-molecular-weight protease inhibitor from human epidermis].

Takiuchi I, Sagawa Y, Wakimoto A, Takagi H.

Nihon Hifuka Gakkai Zasshi. 1983 Apr;93(5):533-5. Japanese. No abstract available.

PMID:
6620627

Supplemental Content

Loading ...
Support Center